SecBot SecBot
COURT-RULING ·Filed Aug 3, 2026

ABBV

AbbVie Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed3mo ago CourtCourt Ruling · govinfo.gov
Actionable Insight • Neutral

This ruling is immaterial to AbbVie. No trading action warranted. Monitor for any future developments only if the plaintiff successfully amends and the case progresses beyond pleading stage, which remains highly unlikely given the procedural posture.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$243.80
T+0 close · Aug 4, 2026 · via day close
Latest settled
+17.47%
T+60 · $286.39
Vs SPY
+17.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $243.80entry
  2. T+1 · 3mo ago +0.98%α +1.18% · $246.20
  3. T+5 · 3mo ago +2.58%α +2.68% · $250.09
  4. T+20 · 3mo ago +6.64%α +7.88% · $259.99
  5. T+60 · 20d ago +17.47%α +17.69% · $286.39
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The U.S. District Court for the Eastern District of Pennsylvania granted AbbVie's motion to dismiss the plaintiff's claims related to a 2021 shooting incident as time-barred, and ordered a more definite statement for claims related to a 2023 fall. This is a routine procedural ruling in a minor product liability case with no material financial exposure to AbbVie, a $433B market cap company. The ruling has no impact on AbbVie's business operations, financials, or stock price.

Court Ruling Details

Ruling Date
Aug 3, 2026
Court
United States District Court for the Eastern District of Pennsylvania
Court Level
District
Judge
Kelley Brisbon Hodge
Case Type
product liability
Ruling Type
motion to dismiss
Outcome
WIN: ruling favors this company
Damages Range
$28 million (as pleaded by plaintiff in the Amended Complaint)
Precedent Risk
LOW
Market Cap Exposure
0.006%

Key Facts

  • AbbVie's motion to dismiss was granted; 2021 claims dismissed with prejudice as time-barred.
  • Plaintiff's 2023 claims require a more definite statement; plaintiff has 30 days to amend.
  • Plaintiff seeks $28 million in compensation, a trivial amount relative to AbbVie's $433B market cap.
  • No injunction, no damages awarded, no precedent risk, and no impact on AbbVie's core business.

Financial Impact

Plaintiff seeks $28 million in compensation, which is approximately 0.006% of AbbVie's $433B market cap. No damages awarded.

Risk Factors

  • If plaintiff successfully amends and states a viable negligence claim on the 2023 incident, minimal discovery costs could arise, but financial exposure remains trivial.

Market Snapshot

Price
$243.74
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (38 analysts)

Investment Themes

Documents Analyzed

This report is based on 2 court opinions.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-5e04217b7d-ABBV
COURT-RULING Data (Synthetic)court-af23a8b180-ABBV

Track record

22 reports on ABBV

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 Now $294.55 +0.22% settles Dec 9
  2. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
  3. Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  4. Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  5. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
  6. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
  8. Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
  9. Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (9h 44m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Aug 4, 2026